Heyholder
‹ Activism Filings

AHN-GOOK PHARMACEUTICAL Co., Ltd. Gwacheon office property acquisition for KRW 163.0 billion

AHN-GOOK PHARMACEUTICAL Co., Ltd.· Material Event Report

AI summary · Not investment advice

AHN-GOOK PHARMACEUTICAL Co., Ltd. will acquire land and an office building in a Gwacheon special planning zone for KRW 163.0 billion, 52.42% of total assets.

Acquisition amount

KRW 163.0 billion

52.42% of total assets · estimated price, settled after completion

Key facts

Asset
Office facility, Special Planning Zone 3, Gwacheon public housing district (land 3,737.95㎡, building 33,058㎡)
% of total assets
52.42%
Counterparty
Medi Park 1 PFV Co.,LtdShares officers or employees with the company
Asset type
Land and building
Board resolution date
Oct 15, 2026

Commentary

AI commentary · Not investment advice

What happened

Ahn-Gook Pharmaceutical will acquire an office building to be constructed in Gwacheon, Gyeonggi-do, together with its land. The property is in Special Planning Zone 3 of the Gwacheon public housing district, with 3,737.95㎡ of land and 33,058㎡ of floor space. The price is KRW 163.0 billion. The seller is the developer, Medi Park 1 PFV Co.,Ltd, which shares officers or employees with Ahn-Gook. The goal is to secure office space for business growth.

In the company's terms

The price equals 52.42% of total assets (KRW 311.0 billion, end of 2025, consolidated). It is an estimate and will be settled at the final price after completion.

What changes for shareholders

Payment is split: a KRW 8.2 billion deposit on October 29, KRW 8.2 billion in October 2028 and KRW 16.3 billion in October 2031. The balance is due at closing. Ownership registration is expected on June 30, 2032.

Comments

No comments yet

Comments from shareholders will appear here.